Barbara Lopez Kunz, CEO of Caidya, shared on LinkedIn:
“Bringing the leadership teams of Caidya and Simbec-Orion together recently only reinforced my confidence in what we are building. There is tremendous energy, complementary expertise, indelible client-focus, and a shared purpose across our organizations.
By connecting early scientific insight with global clinical execution, especially where most transformative medicines are emanating, we are creating a differentiated partner for biopharma innovators from First-in-Human through registration. I am excited for the impact we will continue to have for our clients and ultimately, for patients around the world. Thanks to Fierce for recognizing what we have created at Caidya.”
Quoting Simbec-Orion:
“We’re proud to see the strategic combination of Caidya and Simbec-Orion recognised in recent coverage from Fierce Biotech.
Together, we’ve created a differentiated global CRO with complementary expertise that supports biopharma companies across the full clinical development journey, from First-in-Human through to global clinical development and registration.
Thank you to our employees, clients, and partners for their continued collaboration and commitment.
Read the full article to learn more.”